Hemophilia Gene Therapy Market to Hit USD 3.06 Billion by 2032
“According to a new report published by Introspective Market Research, Hemophilia Gene Therapy Market by Therapy Type, Indication, and End User, The Global Hemophilia Gene Therapy Market Size Was Valued at USD 0.5 Billion in 2023 and is Projected to Reach USD 3.06 Billion by 2032, Growing at a CAGR of 22.3% from 2024–2032.” The Hemophilia Gene Therapy Market is witnessing...
0 Commenti 0 condivisioni 7 Views 0 Anteprima